4
Changes in Ownership
Roivant Sciences Ltd. Filed Acc 0001140361-23-047044
Chief Operating Officer sold 1,200,000 shares at an average $10.43 ($12,520,990)
- Chief Operating Officer acquired 1,200,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Venker Eric Chief Operating Officer | 2023-10-02 | Option exercise 10b5-1 | +440,752 | $3.85 | $1,696,895 | 1,036,149 | D |
| Venker Eric Chief Operating Officer | 2023-10-02 | Sale 10b5-1 | −440,752 | $10.80 | $4,760,122 | 595,397 | D |
| Venker Eric Chief Operating Officer | 2023-10-03 | Option exercise 10b5-1 | +606,221 | $3.85 | $2,333,951 | 1,201,618 | D |
| Venker Eric Chief Operating Officer | 2023-10-03 | Sale 10b5-1 | −606,221 | $10.25 | $6,213,765 | 595,397 | D |
| Venker Eric Chief Operating Officer | 2023-10-04 | Option exercise 10b5-1 | +153,027 | $3.85 | $589,154 | 748,424 | D |
| Venker Eric Chief Operating Officer | 2023-10-05 | Sale 10b5-1 | −153,027 | $10.11 | $1,547,103 | 595,397 | D |
| Derivatives | |||||||
| Venker Eric Chief Operating Officer | 2023-10-02 | Option exercise · Stock Option (Right to Buy) 10b5-1 | −440,752 | 13,382,432 | D | ||
| Venker Eric Chief Operating Officer | 2023-10-03 | Option exercise · Stock Option (Right to Buy) 10b5-1 | −606,221 | 12,776,211 | D | ||
| Venker Eric Chief Operating Officer | 2023-10-04 | Option exercise · Stock Option (Right to Buy) 10b5-1 | −153,027 | 12,623,184 | D | ||
| Open-market sales · 1,200,000 sh · avg $10.43 · $12,520,990 | |||||||
Loading xslF345X05/form4.xml…